chosen on the basis of having experience and expertise with complex cardiac surgery including aortic surgery -no run-ofthe-mill ''valve and CABG guys'' among them! When the answers provided by the thirty respondents were considered as a single group, more than two-thirds of the group had replied ''YES'' with respect to roughly one half of the clinical scenarios. These included such things as:
Pulmonary valve replacement for pulmonary insufficiency in a 22-year-old woman with tetralogy of Fallot who underwent a palliative shunt operation in early infancy followed by intra-cardiac repair with transanular patch at age three years. Re-do aortic and mitral prosthetic valve replacements in a 25-year-old man with Shone syndrome, with history of aortic valvotomy at age one month, aortic valve replacement at six years, mitral valve replacement at 10 years, and aortic and mitral valve replacements with mechanical valves with aortic and mitral anulus enlargement at 14 years Aortic aneurysm repair and pulmonary valve replacement in a 46-year-old man who had undergone repair of tetralogy of Fallot in childhood Ross procedure for regurgitant bicuspid aortic valve in a 25-year-old man with a history of balloon aortic valvuloplasty at age five years Orthotopic heart transplantation with extensive pulmonary artery reconstruction in a 41-year-old woman with history of a prior Fontan operation for tricuspid atresia Mitral valve replacement is a 35-year-old woman status post repair during childhood of an ostium primum ASD Not surprisingly, for some scenarios, the prevalence of positive responses varied across specialty groups among the responders. Ninety percent of the Adult Cardiac Surgeon responders and 83% of Pediatric/Congenital Heart Surgeons replied YES to the question of whether the following scenarios are Adult Congenital Heart Surgery:
Unroofing of an intramural segment of the left main coronary artery in a 28-year-old long-distance runner found to have anomalous aortic origin of the left coronary artery from the right coronary sinus. Tricuspid valvuloplasty with ring, right-sided MAZE in 31-year-old woman who had previous repair of tetralogy of Fallot in childhood, and Melody Valve trans-catheter pulmonary valve insertion at age 28 years.
This last scenario was identified as Adult Congenital Heart Surgery by 100% of Adult Congenital Cardiologists.
But for the other one-half of the scenarios presented, the level of consensus with respect to status as ''Adult Congenital Heart Surgery'' fell short of the two-thirds mark. The following are a few of the scenarios for which we found the responses to be most curious, or even surprising. Roughly one-third of both surgical groups replied YES to the following scenario, which elicited NO affirmative replies from among the Adult Congenital Cardiologists:
Valve-sparing root replacement for 6 cm ascending aorta with mild aortic valve insufficiency in 32-year-old man with Marfan Syndrome And for a complex scenario related to another syndromic heritable connective tissue disease of which aortic involvement is a pathognomonic feature, the responses were even more inconsistent. Affirmative responses were 50% for Adult Cardiac Surgeons but only 15% for both Pediatric/Congenital Heart Surgeons and Adult Congenital Cardiologists for the following:
Aortic arch replacement with debranching in 28-yearold man with Loeys-Dietz Syndrome and history of previous graft replacement of the ascending aorta.
And the following scenario was met with YES responses from 57% of Pediatric/Congenital Cardiac Surgeons, 50% of Adult Cardiac Surgeons, but only 24% of Adult Congenital Cardiologists.
Aortic valve replacement in a 42-year-old woman with history of previous balloon dilation and stent deployment to treat coarctation of thoracic aorta.
For a variety of scenarios related to bicuspid aortic valve with or without previous balloon intervention or to bicuspid aortic valve without ascending aortic enlargement, threefourths of the Adult Congenital Cardiologists affirmatively identified most of these as Adult Congenital Heart Surgery. Affirmative responses were less prevalent and less consistent across both groups of surgeons. The highest rate of affirmative responses from surgeons was for ''Aortic valvuloplasty for regurgitant bicuspid aortic valve in a 25-year-old man with a history of balloon aortic valvuloplasty at age 2 years'' and the lowest rate of affirmative responses from surgeons was for ''Aortic valve replacement and ascending aortic graft replacement in 46-year-old man with bicuspid aortic valve and ascending aortic enlargement.'' Finally, we were surprised that ''Extended left ventricular myomectomy in 31-year-old man with Hypertrophic Obstructive Cardiomyopathy'' was affirmatively identified as ACHS by 40% of Adult Cardiac Surgeons, by 53% of Pediatric/Congenital Cardiac Surgeons and by none of the Adult Congenital Cardiologists.
So, our little foray into individual practitioners' opinions as to ''What Is Adult Congenital Heart Surgery'' brought us back to Molly Bawn. Like beauty, one must conclude that Adult Congenital Heart Surgery is ''in the eye of the beholder.'' That having been said, Adult Congenital Heart Disease and Adult Congenital Heart Surgery are also the subject of post-graduate education and clinical training for young physicians in medical and surgical sub-specialties. They are the subject of text books, the raison d'être of advocacy organizations, and even the target of legislation and public health budget acts. And importantly, they are the subject of guidelines and consensus papers produced regularly by professional societies around the world. Take the example of Marfan Syndrome. Aortic root dilatation is a pathognomonic feature of this heritable connective tissue disease. Valve sparing aortic root replacement for a patient with Marfan syndrome was affirmatively identified as Adult Congenital Heart Surgery by less than one-half of the respondents and by none of the Adult Congenital Cardiologists. 3 and dedicated a detailed section to Marfan syndrome, including diagnostic work-up, medical therapy, surgical and interventional treatment, and additional considerations including pregnancy. Inclusion of such detailed and comprehensive coverage of Marfan syndrome and its pathognomonic aortopathy and mitral valve abnormalities seem, in the collective opinion of the European Society of Cardiology, to merit major consideration alongside such things as conotruncal anomalies, septal defects, abnormalities of atrioventricular and ventriculoarterial connection, Ebstein malformation, and univentricular heart. This appears to be true in most, but not all guideline papers addressing the subject of congenital heart disease in adult patients. To a lesser extent, hypertrophic cardiomyopathy, a primary disease of the myocardium which is attributed to mutations in one of a number of genes that encode for one of the sarcomere proteins, is also a form of heritable heart disease that may present clinical manifestations early in childhood (as is often the case in Noonan syndrome patients), later in childhood, or during adult life.
Increasingly, we are being asked ''How much Adult Congenital Heart Surgery is done at your center?'' The question is posed by patients and their families, by insurance companies and third party payers seeking to identify centers with multidisciplinary experience in the surgical management of adult patients with congenital heart disease, and by various organizations who purport to rank providers on the basis of resources, numbers of patients served, and outcomes. We believe it is appropriate to recognize the breadth of the spectrum of ''Adult Congenital Heart Surgery.'' It is obvious that patients who have survived to adulthood with congenital heart disease, some following palliative or reparative interventions and surgical procedures during infancy and childhood, are a rapidly expanding population. Many of these patients will require further surgical interventions during adult life. Certainly we should acknowledge that this includes management of bicuspid aortic valve, the most common congenital cardiac defect, even in patients who did not require catheter directed or surgical interventions early in life. Likewise, we should acknowledge that surgery for heritable conditions such as aortopathies due to connective tissue diseases, when performed on adult patients, is Adult Congenital Heart Surgery. McKusick wrote: ''Before the era of open-heart surgery, the majority of patients with Marfan syndrome died prematurely of rupture of the aorta, with an average life expectancy of 45 years.'' 4 If an individual is recognized early in childhood as having a disease that carries a very high risk of one day requiring heart surgery for a pathognomonic phenotypic expression of that disease, and is followed through childhood and adolescence to monitor the status of that condition, and eventually requires surgery during adulthood . . . . then surely that surgery is congenital heart surgery. Similar logic may be applied to primary genetically-based diseases of the myocardium.
Contemporary estimates suggest that 85% of patients born with congenital heart disease in the United States survive into adult life. There are more than 2 million infants, children, adolescents, and adults living with congenital heart disease in the United States alone. For the first time, it is estimated that the number of adults in the U.S. living with congenital heart disease is larger the number of children living with congenital heart disease. 5 The emergence of an ever larger population of patients surviving to adulthood with congenital heart disease reflects very positively on the community of individuals and organizations that have cared for these patients over the last many decades. 6 But it should also remind us that, with the exception of the very simplest anomalies, the vast majority of forms of congenital heart disease are actually chronic diseases, with lifelong implications for patients' health and well-being, and for the societal platforms and health care resources that must adapt in order to ensure that congenital heart disease patients of all ages have access to appropriate professional expertise and care. When you are asked ''How much Adult Congenital Heart Surgery is done at your center?'' do not think of the question as though it was intended for a scorecard or a ranking system. Think of it rather, as a piece of the puzzle that will ultimately help us to plan for, and optimize the care and long-term functional health status of a growing segment of the world's population.
